LungLife AI, Inc. (the “Company” or “LungLife”) Notice of Results Investor Presentation LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, will announce its full year results for the year ended 31 December 2022 on Monday 20 February 2023. Investor presentation Paul Pagano, Chief Executive Officer, and David Anderson, Chief Financial […]
LungLife AI licensure/accreditation information posted here.